Jane D. Englebright, SVP and Chief Nursing Officer at HCA Healthcare, Inc. (HCA), sold 10,902 shares at $175.75 ($1.9M) on 2021-02-23, disclosed to the SEC on 2021-02-25.
Seasonal sale ($1.9M) by SVP and Chief Nursing Officer — this insider has traded HCA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $174.06 | 2,090 | $364K | 19.1% |
| 2 | $174.06 | 2,090 | $364K | 19.1% |
| 3 | $175.03 | 3,061 | $536K | 28.1% |
| 4 | $175.03 | 3,061 | $536K | 28.1% |
| 5 | $175.75 | 600 | $105K | 5.5% |
| Total | $174.70 avg | 10,902 |
| $1.9M |
| 100% |
| Filing → |
| HCA | SELL | 2021-08-03 | $927K | — | Filing → |
| HCA | SELL | 2021-07-29 | $50K | — | Filing → |
| HCA | SELL | 2020-11-09 | $1.3M | — | Filing → |